Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25373 | 235 | 46.0 | 96% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FBXW7 | Author keyword | 28 | 56% | 14% | 34 |
2 | FBW7 | Author keyword | 22 | 53% | 13% | 30 |
3 | HCDC4 | Author keyword | 6 | 100% | 2% | 4 |
4 | FBXO31 | Author keyword | 3 | 57% | 2% | 4 |
5 | RING FINGER PROTEIN 180 | Author keyword | 2 | 67% | 1% | 2 |
6 | FBXL20 | Author keyword | 1 | 100% | 1% | 2 |
7 | PHOSPHODEGRON | Author keyword | 1 | 33% | 1% | 3 |
8 | SCF COMPLEX | Author keyword | 1 | 10% | 3% | 7 |
9 | BIOTECHNOL KTH | Address | 1 | 50% | 0% | 1 |
10 | BRAIN TUMOR DEVELOPMENT | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FBXW7 | 28 | 56% | 14% | 34 | Search FBXW7 | Search FBXW7 |
2 | FBW7 | 22 | 53% | 13% | 30 | Search FBW7 | Search FBW7 |
3 | HCDC4 | 6 | 100% | 2% | 4 | Search HCDC4 | Search HCDC4 |
4 | FBXO31 | 3 | 57% | 2% | 4 | Search FBXO31 | Search FBXO31 |
5 | RING FINGER PROTEIN 180 | 2 | 67% | 1% | 2 | Search RING+FINGER+PROTEIN+180 | Search RING+FINGER+PROTEIN+180 |
6 | FBXL20 | 1 | 100% | 1% | 2 | Search FBXL20 | Search FBXL20 |
7 | PHOSPHODEGRON | 1 | 33% | 1% | 3 | Search PHOSPHODEGRON | Search PHOSPHODEGRON |
8 | SCF COMPLEX | 1 | 10% | 3% | 7 | Search SCF+COMPLEX | Search SCF+COMPLEX |
9 | BRAIN TUMOR DEVELOPMENT | 1 | 50% | 0% | 1 | Search BRAIN+TUMOR+DEVELOPMENT | Search BRAIN+TUMOR+DEVELOPMENT |
10 | DIRECT BISULFITE GENOMIC SEQUENCING | 1 | 50% | 0% | 1 | Search DIRECT+BISULFITE+GENOMIC+SEQUENCING | Search DIRECT+BISULFITE+GENOMIC+SEQUENCING |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HCDC4 | 49 | 82% | 12% | 28 |
2 | FBW7 UBIQUITIN LIGASE | 28 | 60% | 13% | 31 |
3 | PHOSPHORYLATION DEPENDENT DEGRADATION | 24 | 67% | 9% | 22 |
4 | SCFFBW7 | 23 | 86% | 5% | 12 |
5 | SCFFBW7 UBIQUITIN LIGASE | 21 | 65% | 9% | 20 |
6 | FBW7 | 13 | 42% | 10% | 24 |
7 | HCDC4 GENE | 11 | 100% | 3% | 6 |
8 | CYCLIN E | 10 | 11% | 35% | 83 |
9 | FBXW7 ACTS | 8 | 100% | 2% | 5 |
10 | FBXW7 HCDC4 | 8 | 100% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation | 2008 | 372 | 105 | 40% |
Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities | 2014 | 8 | 100 | 60% |
Tumor suppressor functions of FBW7 in cancer development and progression | 2012 | 40 | 95 | 46% |
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation | 2010 | 48 | 76 | 41% |
Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells | 2014 | 3 | 30 | 50% |
Role of the ubiquitin ligase Fbw7 in cancer progression | 2012 | 31 | 145 | 32% |
Emerging roles of the FBW7 tumour suppressor in stem cell differentiation | 2012 | 16 | 82 | 39% |
Aberrant regulation of FBW7 in cancer | 2014 | 4 | 188 | 24% |
The Fbxw7/hCdc4 tumor suppressor in human cancer | 2008 | 35 | 92 | 30% |
Control of genomic instability and epithelial tumor development by the p53-Fbxw7/Cdc4 pathwayle | 2005 | 20 | 31 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOTECHNOL KTH | 1 | 50% | 0.4% | 1 |
2 | CEDARS SINAI WOMENS CANC GYNECOL ONC | 1 | 50% | 0.4% | 1 |
3 | CENT TIANJIN CANC | 1 | 50% | 0.4% | 1 |
4 | GASTROENTEROLTIANJIN CANC | 1 | 50% | 0.4% | 1 |
5 | IMMUNOSURVEILLANCE | 1 | 50% | 0.4% | 1 |
6 | MAX PLANK | 1 | 50% | 0.4% | 1 |
7 | PREVENT MED TOXICOL | 1 | 50% | 0.4% | 1 |
8 | DRISKILL PROGRAM LIFE SCI | 1 | 25% | 0.9% | 2 |
9 | CANCER KAROLINSKA | 0 | 33% | 0.4% | 1 |
10 | CENT HOSP 155 | 0 | 33% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000288094 | COP9 SIGNALOSOME//NEDD8//NEDDYLATION |
2 | 0.0000153845 | CYCLIN D1//CYCLIN E//CCND1 |
3 | 0.0000131889 | SKP2//P27KIP1//P27 |
4 | 0.0000126889 | MYC//MAX//C MYC |
5 | 0.0000097375 | NOTCH//NOTCH SIGNALING//NOTCH1 |
6 | 0.0000082627 | WWP1//SMURF1//CKIP 1 |
7 | 0.0000074461 | PIN1//ESS1//WW DOMAIN |
8 | 0.0000065081 | KLF6//KLF4//KRUPPEL LIKE FACTOR 4 |
9 | 0.0000055816 | DSK2//UBIQUILIN 1//LUBAC |
10 | 0.0000055755 | CXCL14//DBC2//BRAK |